Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2010

Open Access 01-12-2010 | Research article

Toll-like receptor gene polymorphisms are associated with susceptibility to graves' ophthalmopathy in Taiwan males

Authors: Wen-Ling Liao, Rong-Hsing Chen, Hui-Ju Lin, Yu-Huei Liu, Wen-Chi Chen, Yuhsin Tsai, Lei Wan, Fuu-Jen Tsai

Published in: BMC Medical Genetics | Issue 1/2010

Login to get access

Abstract

Background

Toll-like receptors (TLRs) are a family of pattern-recognition receptors, which plays a role in eliciting innate/adaptive immune responses and developing chronic inflammation. The polymorphisms of TLRs have been associated with the risk of various autoimmune diseases, including systemic lupus erythematosus (SLE), multiple sclerosis and rheumatorid arthritis. The aim of this study was to evaluate whether TLR genes could be used as genetic markers for the development of Graves' ophthalmopathy (GO).

Methods

6 TLR-4 and 2 TLR-9 gene polymorphisms in 471 GD patients (200 patients with GO and 271 patients without GO) from a Taiwan Chinese population were evaluated.

Results

No statistically significant difference was observed in the genotypic and allelic frequencies of TLR-4 and TLR-9 gene polymorphisms between the GD patients with and without GO. However, sex-stratified analyses showed that the association between TLR-9 gene polymorphism and GO phenotype was more pronounced in the male patients. The odds ratios (ORs) was 2.11 (95% confidence interval [CI] = 1.14-3.91) for rs187084 AàG polymorphism and 1.97 (95% CI = 1.07-3.62) for rs352140 AàG polymorphism among the male patients. Increasing one G allele of rs287084 and one A allele of rs352140 increased the risk of GO (p values for trend tests were 0.0195 and 0.0345, respectively). Further, in haplotype analyses, the male patients carrying the GA haplotype had a higher risk of GO (odds ratio [OR] = 2.02, 95% confidence interval [CI] = 1.09-3.73) than those not carrying the GA haplotype.

Conclusion

The present data suggest that TLR-9 gene polymorphisms were significantly associated with increased susceptibility of ophthalmopathy in male GD patients.
Appendix
Available only for authorised users
Literature
1.
Mishra A, Mishra SK: Multicentre study of thyroid nodules in patients with Graves' disease (Br J Surg 2000; 87: 1111-13). Br J Surg. 2001, 88 (2): 313-10.1046/j.1365-2168.2001.01729-3.x.CrossRefPubMed
2.
Gianoukakis AG, Smith TJ: Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes. 2008, 15 (5): 446-452.CrossRefPubMedPubMedCentral
3.
Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA: Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye (Lond). 2010, 24 (6): 1058-1063.CrossRef
4.
Lin MC, Hsu FM, Bee YS, Ger LP: Age influences the severity of Graves' ophthalmopathy. Kaohsiung J Med Sci. 2008, 24 (6): 283-288. 10.1016/S1607-551X(08)70154-2.CrossRefPubMed
5.
Tomer Y, Huber A: The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009, 32 (3-4): 231-239. 10.1016/j.jaut.2009.02.007.CrossRefPubMedPubMedCentral
6.
McGrogan A, Seaman HE, Wright JW, de Vries CS: The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf). 2008, 69 (5): 687-696. 10.1111/j.1365-2265.2008.03338.x.CrossRef
7.
Lim SL, Lim AK, Mumtaz M, Hussein E, Wan Bebakar WM, Khir AS: Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease. Thyroid. 2008, 18 (12): 1297-1301. 10.1089/thy.2008.0044.CrossRefPubMed
8.
Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, Lazarus JH, Pearce SH, Vaidya B, Gough SC, et al: Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab. 2006, 91 (12): 4873-4880. 10.1210/jc.2006-1402.CrossRefPubMed
9.
Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, et al: Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab. 2007, 92 (8): 3162-3170. 10.1210/jc.2007-0147.CrossRefPubMed
10.
Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 2000, 165 (11): 6606-6611.CrossRefPubMed
11.
Weetman AP: The genetics of autoimmune thyroid disease. Horm Metab Res. 2009, 41 (6): 421-425. 10.1055/s-0029-1214415.CrossRefPubMed
12.
Liu YH, Chen RH, Chen WC, Tsai Y, Wan L, Tsai FJ: Disease association of the CD103 polymorphisms in Taiwan Chinese Graves' ophthalmopathy patients. Ophthalmology. 2010, 117 (8): 1645-1651. 10.1016/j.ophtha.2009.12.037.CrossRefPubMed
13.
Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP: Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci. 2008, 49 (6): 2409-2415. 10.1167/iovs.07-1433.CrossRefPubMed
14.
Drexler SK, Foxwell BM: The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010, 42 (4): 506-518. 10.1016/j.biocel.2009.10.009.CrossRefPubMed
15.
Caturegli P, Kimura H, Rocchi R, Rose NR: Autoimmune thyroid diseases. Curr Opin Rheumatol. 2007, 19 (1): 44-48. 10.1097/BOR.0b013e3280113d1a.CrossRefPubMed
16.
Fischer M, Ehlers M: Toll-like receptors in autoimmunity. Ann N Y Acad Sci. 2008, 1143: 21-34. 10.1196/annals.1443.012.CrossRefPubMed
17.
O'Neill LA: The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev. 2008, 226: 10-18. 10.1111/j.1600-065X.2008.00701.x.CrossRefPubMed
18.
Midwood KS, Piccinini AM, Sacre S: Targeting Toll-like receptors in autoimmunity. Curr Drug Targets. 2009, 10 (11): 1139-1155. 10.2174/138945009789735101.CrossRefPubMed
19.
Montero Vega MT, de Andres Martin A: Toll-like receptors: a family of innate sensors of danger that alert and drive immunity. Allergol Immunopathol (Madr). 2008, 36 (6): 347-357. 10.1016/S0301-0546(08)75868-3.CrossRef
20.
Krieg AM, Vollmer J: Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007, 220: 251-269. 10.1111/j.1600-065X.2007.00572.x.CrossRefPubMed
21.
Hurst J, von Landenberg P: Toll-like receptors and autoimmunity. Autoimmun Rev. 2008, 7 (3): 204-208. 10.1016/j.autrev.2007.11.006.CrossRefPubMed
22.
von Landenberg P, Bauer S: Nucleic acid recognizing Toll-like receptors and autoimmunity. Curr Opin Immunol. 2007, 19 (6): 606-610. 10.1016/j.coi.2007.10.004.CrossRefPubMed
23.
Dezsofi A, Szebeni B, Hermann CS, Kapitany A, Veres G, Sipka S, Korner A, Madacsy L, Korponay-Szabo I, Rajczy K, et al: Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J Pediatr Gastroenterol Nutr. 2008, 47 (3): 283-287. 10.1097/MPG.0b013e31816de885.CrossRefPubMed
24.
Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC: Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens. 2005, 65 (3): 266-270. 10.1111/j.1399-0039.2005.00374.x.CrossRefPubMed
25.
Kang ES, Lee J: Genotypic analysis of Asp299Gly and Thr399Ile polymorphism of Toll-like receptor 4 in systemic autoimmune diseases of Korean population. Rheumatol Int. 2007, 27 (9): 887-889. 10.1007/s00296-007-0311-z.CrossRefPubMed
26.
Ng MW, Lau CS, Chan TM, Wong WH, Lau YL: Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology (Oxford). 2005, 44 (11): 1456-1457. 10.1093/rheumatology/kei120.CrossRef
27.
Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P, Joosten LA, van Riel PL, van den Berg WB: The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum. 2004, 50 (3): 999-1001. 10.1002/art.20114.CrossRefPubMed
28.
Reindl M, Lutterotti A, Ingram J, Schanda K, Gassner C, Deisenhammer F, Berger T, Lorenz E: Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens. 2003, 61 (1): 85-88. 10.1034/j.1399-0039.2003.610108.x.CrossRefPubMed
29.
Sheedy FJ, Marinou I, O'Neill LA, Wilson AG: The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to, or severity of, rheumatoid arthritis. Ann Rheum Dis. 2008, 67 (9): 1328-1331. 10.1136/ard.2007.083337.CrossRefPubMed
30.
Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, et al: Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007, 66 (7): 905-909. 10.1136/ard.2006.065961.CrossRefPubMedPubMedCentral
31.
Urcelay E, Blanco-Kelly F, de Las Heras V, de la Concha EG, Arroyo R, Martinez A: TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population. J Neuroimmunol. 2007, 192 (1-2): 215-218. 10.1016/j.jneuroim.2007.10.001.CrossRefPubMed
32.
Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, et al: A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007, 449 (7164): 851-861. 10.1038/nature06258.CrossRefPubMed
33.
Consortium TIH: A haplotype map of the human genome. Nature. 2005, 437 (7063): 1299-1320. 10.1038/nature04226.CrossRef
34.
Project TIH: The International HapMap Project. Nature. 2003, 426 (6968): 789-796. 10.1038/nature02168.CrossRef
35.
Consortium TIH: Integrating ethics and science in the International HapMap Project. Nat Rev Genet. 2004, 5 (6): 467-475. 10.1038/nrg1351.CrossRef
36.
37.
Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, Cornelis F, Boissier MC, Falgarone G: No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther. 2009, 11 (1): R5-10.1186/ar2589.CrossRefPubMedPubMedCentral
38.
Xu CJ, Zhang WH, Pan HF, Li XP, Xu JH, Ye DQ: Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese. Mol Biol Rep. 2009, 36 (8): 2245-2248. 10.1007/s11033-008-9440-z.CrossRefPubMed
39.
Ronnblom L, Eloranta ML, Alm GV: The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 2006, 54 (2): 408-420. 10.1002/art.21571.CrossRefPubMed
40.
Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA: Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab. 2000, 85 (3): 1038-1042. 10.1210/jc.85.3.1038.PubMed
41.
Senthilselvan A, Chenard L, Kirychuk S, Predicala B, Schwartz DA, Burch LH, Rennie DC, Willson PJ, Dosman JA: Gender-Related Tumor Necrosis Factor-alpha Responses in Naive Volunteers With Toll-Like Receptor 4 Polymorphisms Exposed in a Swine Confinement Facility. J Interferon Cytokine Res. 2009
Metadata
Title
Toll-like receptor gene polymorphisms are associated with susceptibility to graves' ophthalmopathy in Taiwan males
Authors
Wen-Ling Liao
Rong-Hsing Chen
Hui-Ju Lin
Yu-Huei Liu
Wen-Chi Chen
Yuhsin Tsai
Lei Wan
Fuu-Jen Tsai
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2010
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-11-154

Other articles of this Issue 1/2010

BMC Medical Genetics 1/2010 Go to the issue

Erratum

Erratum to: Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer

Research article

Polymorphisms in IL-1β, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis

Research article

A novel syndrome of paediatric cataract, dysmorphism, ectodermal features, and developmental delay in Australian Aboriginal family maps to 1p35.3-p36.32

Research article

Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes

Research article

Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in Type 2 Diabetes in a Chinese population

Research article

Nuclear Factor (NF) κB polymorphism is associated with heart function in patients with heart failure